Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of patient assistance programs and information on financial assistance provided to pharmacies, government agencies and advocacy organizations. Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of patient assistance programs and information on financial assistance provided to pharmacies, government agencies and advocacy organizations. Excludes proprietary information from disclosure on department's website.
Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers.
Requires insurers to post specified information regarding formulary, tiers and costs to insurer's website. Requires 60-day advance notice to enrollees adversely affected by change in formulary.
Requires insurer and allows pharmacy to notify insured that if cash price for drug is less than insured's cost-share for drug, insured may pay cash price and expense must be counted toward deductible or out-of-pocket maximum.
Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers.
Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost.
Requires patient advocacy organization with budget exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority specified information regarding funding received from participants in pharmaceutical supply chain.
Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies.
Requires drug advertisement to disclose wholesale price of drug.
Chapter Number:
Fiscal Impact:
May Have Fiscal Impact, But No Statement Yet Issued
Revenue Impact:
May Have Revenue Impact, But No Statement Yet Issued
Oregon Legislative Assembly - Public Testimony Registration Form
You are registering to speak about:
HB 3093 House Committee On Health Care
Registration Instructions
Submit the form below to testify or comment either in person or remotely by video or phone. After completing the required fields (*), click the “Submit Registration to Testify” button.
Email address and phone number are required for administrative purposes and will not be posted to OLIS. Your phone number will be displayed on the livestream of the committee meeting if you testify by phone.
Registration ends 30 minutes prior to the start of the meeting. After that time, the registration system will close.
After registering and seeing a confirmation screen, you will receive an email with meeting details. If you do not receive a confirmation email, check your email spam folder.
Registration does not guarantee that you will have an opportunity to speak; the chair may determine that time for public testimony will be limited. Committee meetings are sometimes cancelled or rescheduled. You can receive email updates on selected bills or committee agendas by signing up for Capitol e-Subscribe.
If you would like to provide written testimony to the committee, see instructions to submit written testimony here.
To request spoken language interpretation, American Sign Language (ASL) interpretation, or Communication Access Realtime Translation (CART) services, please email languageaccess@oregonlegislature.gov or call 503-986-1538 at least 3 days in advance.
Para solicitar servicios de interpretación de lenguaje hablado, interpretación de lenguaje de señas americano (ASL) o traducción en tiempo real de acceso a la comunicación (CART), envíe un correo electrónico a languageaccess@oregonlegislature.gov o llame al 503-986-1538 con 3 dias de anticipación.
Confidential - Administrative Use Only
Will you travel more than 100 miles to this meeting to testify?
You Have Successfully Registered to Testify
Testimony Details:
You will receive an email soon with meeting details. If you registered to testify remotely, the
email will include a link or phone number to join the committee meeting.
If you do not receive a confirmation within 24 hours, have any questions, or need to cancel your registration,
please call 1-833-588-4500 or email the committee assistant listed on the committee page on OLIS.
Committee meetings are sometimes canceled or rescheduled. If you register to testify and the meeting is
rescheduled, you will need to register for the new meeting date. To receive email updates on selected
bills or committee agendas, sign up for Capitol E-Subscribe.
Measure Not Scheduled for Public Testimony
Thank you for your interest in providing public testimony on measure .
Either this measure is not currently scheduled for a public hearing, or the deadline to register to testify
or to submit written testimony has passed.
For questions about the legislature, legislative process, or other government agencies, please email
help.leg@oregonlegislature.gov or call 1-800-332-2313.
Measure Not Scheduled for Public Testimony
Thank you for your interest in providing written testimony on measure .
Either this measure is not currently scheduled for a public hearing, or the deadline to register to testify
or to submit written testimony has passed.
For questions about the legislature, legislative process, or other government agencies, please email
help.leg@oregonlegislature.gov or call 1-800-332-2313.